Coloplast A/S (CLPBY) Stock: Price, Forecast & Analyst Target
Coloplast A/S (CLPBY) — price $7.28 (-0.82%), as of the Nov 19, 2026 trading session; market cap $16.4B.
Educational signal · not a buy or sell recommendation · How to read this
Coloplast A/S · CLPBY · Healthcare · Medical - Instruments & Supplies
Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $7.28 | |
| Change on the day | -0.82% | |
| 52-week range | $5.64–$9.29 | |
| Market capitalisation | $16.4B | — |
| Price / earnings (trailing) | 37.35 | |
| Shares traded on the day | 11.0K | |
| Beta (volatility vs the S&P 500) | 0.53 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Coloplast A/S (CLPBY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 7, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Coloplast A/S (CLPBY), and what does it report?
Short answer
Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Healthcare / Medical Instruments & Supplies SEC filing business address: Holtedam 1, DK-3050, G7, 00000. It employs 17,524 people and is led by Gavin Wood. In Q4 FY2026 it reported revenue of kr7.41B and net income of kr1.18B. The market values it at $16.4B.
What do the latest results show for Coloplast A/S (CLPBY)?
Short answer · as of
The most recent reported quarter, Q4 FY2026, carried revenue of kr7.41B. Against analyst estimates the company has EPS beat 4 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2026 | kr7.41B | kr1.18B | kr0.52 (diluted) |
| Q3 FY2026 | kr7.48B | kr1.49B | kr0.65 (diluted) |
| Q2 FY2026 | kr7.20B | -kr987M | -kr0.44 (diluted) |
| Q1 FY2026 | kr7.04B | kr1.38B | kr0.61 (diluted) |
What are the financial strengths and risks for Coloplast A/S (CLPBY)?
Short answer · as of
The distress and quality screens read Altman Z 3.65 · Piotroski F 6. Trailing ratios: ROE 22.6% · ROA 6.6% · current ratio 0.74 · earnings yield 2.7% · free-cash-flow yield 5.8%.
What should you watch next at Coloplast A/S (CLPBY)?
Short answer · as of
Current published price targets run low $7.38 · high $7.38 · consensus $7.38 · median $7.38 against a quoted price of $7.28 (as of Nov 19, 2026).
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $7.38 – $7.38
- Consensus target
- $7.38
- Median target
- $7.38
Consensus record · Captured .
Measured against a quoted price of $7.28 (as of Nov 19, 2026).
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held CLPBY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported CLPBY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Coloplast A/S (CLPBY)?
CLPBY Healthcare Stock FAQ
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
How do SenSura Mio and SpeediCath differ from Coloplast’s surgical urology products?
SenSura Mio ostomy appliances and SpeediCath catheters support ongoing condition management and repeat use. Surgical urology devices are tied more closely to procedures addressing stones, prostate conditions, voiding dysfunction, erectile dysfunction and incontinence.
Why can Coloplast’s organic growth exceed its reported growth?
Management expects currency movements to reduce reported revenue growth even while the underlying business expands organically. The same pressure is expected to weigh on reported operating margin.
What is the CLPBY stock price today?
The last price recorded for Coloplast A/S (CLPBY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CLPBY price target?
The analyst consensus price target for Coloplast A/S (CLPBY), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 24 figures on this page — 1 from SEC filings and earnings calls, 18 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com